Jean Katow, M.D. is a board-certified ophthalmologist who specializes in general ophthalmology, ophthalmic plastics, and reconstructive surgery. She obtained her Bachelors degree at the University of California, Los Angeles and subsequently attended the University of California, Davis for her Medical Degree. She completed her residency in ophthalmology at the University of Louisville and her fellowship in ophthalmic plastics at the University of Cincinnati. Dr. Katow has been practicing for nearly 20 years and is involved in humanitarian missions to foreign countries in need of medical care. She is a member of the American Academy of Ophthalmology, the California Association of Ophthalmology, and the Los Angeles Ophthalmological Society.
Jean P. Katow
Medical Education
University of California, Davis Medical SchoolDavis, California 95616
University of Southern California, 3551 University Avenue, Los Angeles, California 90089Graduate Courses, Biological Sciences
University of California405 Hilgard Avenue, Westwood, California 90024 B.A., Zoology
Postgraduate Training and Fellowship Appointments
Ophthalmic Plastics and Reconstructive Surgery Fellowship University of Cincinnati, Dept. of Ophthalmology, Cincinnati, Ohio. Dwight Kulwin, M.D., University of Cincinnati, The Barrett Center, 234 Goodman, ML 670, Cincinnati, Ohio 45267
Ophthalmology Residency, University of Louisville School of Medicine, Department of Ophthalmology, 301 East Muhammed Ali Boulevard, Louisville, KY 40202
Flexible Residency, White Memorial Medical Center, 1720 Brooklyn Avenue, Los Angeles, CA 90033
Research Experience
October 2001 - Dec 2001
Evaluation of the efficacy and safety of Ketotifen Fumarate 0.025% Ophthalmic Solution Compared to Vehicle Placebo in a Pediatric Population in the Allergen Challenge Model of Allergic Conjunctivitis, Following a Single Dose and Four Week Treatment. Norvartis Ophthalmics.
May 2001 - Aug 2001
Lumigan Early Experience Data Study 2001. Allergan Inc.
Apr 2001 - Jun 2001
A Multi-Center, Randomized, Double Masked, Parallel Group Study Evaluating the Efficacy and Safety of Epinastine Hydrochloride 0.05% Ophthalmic Solution Compared to Vehicle of Epinastine or to Levocabastine 0.05% Ophthalmic Suspension used Twice Daily for Eight Weeks in an Environmental Study in Adult and Pediatric Patients with Seasonal Allergic Conjunctivitis. Allergan Inc.
Nov 2000 - Dec 2000
A Dose-Response, Placebo-Controlled Study of Olopatadine Ophthalmic Solutions Using the Conjunctival Antigen Challenge (CAC) Model of Acute Allergic Conjunctivitis in Japanese Subjects. Alcon.
Hospital Affiliations
- St. Vincent Medical Center – Courtesy
- 2131 West Third Street, Los Angeles, California 90057
- Third Street Surgery Center – Active
- 420 East Third Street, Suite 110, Los Angeles, California 90013
- St. Vincent Eye Surgery Institute – Active
- 201 South Alvarado Street, Suite 718 Los Angeles, California 90057
- Good Samaritan Hospital – Courtesy
- 1225 Wilshire Boulevard., Los Angeles, California 90017
- Surgery Center of South Bay – Temporary
- 23599 Madison Street, Torrance, California 90505
Licensure
- California
- Ohio
- Hawaii
Certification
- Board Certified in Ophthalmology – May 1988
Membership in Professional Organizations
- American Academy of Ophthalmology
- California Association of Ophthalmology
- Los Angeles Ophthalmology Society 1974
© 2024 East West Eye Institute. All rights reserved.